o NoneEntity Type
0001533998
Labstyle Innovations Corp.
LabStyle Innovations Corp.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 DarioHealth Corp.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 DarioHealth Corp. 
Street Address 1Street Address 2
 142 W. 57TH ST., 8TH FLOOR 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 NEW YORK NEW YORK 10019 (646) 665-4667 



3. Related Persons
Last NameFirst NameMiddle Name
RaphaelErez
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Ben-DavidZvi
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
BacherDror
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
AndersonRichard
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
ShakedYoav
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
SternAdam
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
MatheisDennis
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
KarahHila
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
McGrathDennisM.
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
StoneRichardB
Street Address 1Street Address 2
142 W. 57th St., 8th Floor
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10019
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2021-06-07 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? x Yes o No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 24000000 USD o Indefinite
Total Amount Sold $ 24000000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 Total Amount Sold includes $2,750,000 of shares of Common Stock held back to secure indemnification obligations and $5,000,000 of shares of Common Stock issuable based on the earn-out provisions of the Issuer's May 15, 2021 Merger Agreement.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 74


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more DarioHealth Charts.
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more DarioHealth Charts.

Dariohealth Corp. News

Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
Thursday 25 April 2024 (1 week ago) • PR Newswire (US)
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
Thursday 18 April 2024 (2 weeks ago) • PR Newswire (US)
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
Wednesday 10 April 2024 (3 weeks ago) • PR Newswire (US)
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Thursday 28 March 2024 (1 month ago) • PR Newswire (US)
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
Thursday 21 March 2024 (1 month ago) • PR Newswire (US)
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
Tuesday 12 March 2024 (2 months ago) • PR Newswire (US)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

More Dariohealth Corp. News Articles